AstraZeneca PLC (Sweden) Today
| AZN Stock | SEK 1,503 10.50 0.70% |
Performance8 of 100
| Odds Of DistressLess than 9
|
AstraZeneca PLC is selling for under 1503.00 as of the 18th of April 2024; that is 0.70 percent increase since the beginning of the trading day. The stock's last reported lowest price was 1484.5. AstraZeneca PLC has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat ok performance during the last 90 days. Equity ratings for AstraZeneca PLC are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 19th of March 2024 and ending today, the 18th of April 2024. Click here to learn more.
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom. AstraZeneca PLC operates under Drug ManufacturersGeneral classification in Sweden and is traded on Stockholm Stock Exchange. The company has 1.55 B outstanding shares. More on AstraZeneca PLC
Moving against AstraZeneca Stock
| 0.6 | EXPRS2 | ExpreS2ion Biotech | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
AstraZeneca Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. AstraZeneca PLC's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding AstraZeneca PLC or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Pascal Soriot |
| Business Concentration | Drug Manufacturers—General, Healthcare (View all Sectors) |
AstraZeneca PLC (AZN) is traded on Stockholm Exchange in Sweden and employs 37 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 2.26 T. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate AstraZeneca PLC's market, we take the total number of its shares issued and multiply it by AstraZeneca PLC's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. AstraZeneca PLC operates under Healthcare sector and is part of Drug Manufacturers—General industry. The entity has 1.55 B outstanding shares.
AstraZeneca PLC has accumulated about 4.89 B in cash with 9.81 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.15.
Check AstraZeneca PLC Probability Of Bankruptcy
Ownership AllocationAstraZeneca PLC holds a total of 1.55 Billion outstanding shares. 30% of AstraZeneca PLC outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check AstraZeneca Ownership Details
AstraZeneca Stock Price Odds Analysis
Attributed to a normal probability distribution, the odds of AstraZeneca PLC jumping above the current price in 90 days from now is about 1.19%. The AstraZeneca PLC probability density function shows the probability of AstraZeneca PLC stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon AstraZeneca PLC has a beta of -0.4187. This suggests as returns on the benchmark increase, returns on holding AstraZeneca PLC are expected to decrease at a much lower rate. During a bear market, however, AstraZeneca PLC is likely to outperform the market. Additionally, astraZeneca PLC has an alpha of 0.1241, implying that it can generate a 0.12 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of AstraZeneca PLC to move above the current price in 90 days from now is about 1.19 (This AstraZeneca PLC probability density function shows the probability of AstraZeneca Stock to fall within a particular range of prices over 90 days) .
AstraZeneca PLC Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. AstraZeneca PLC market risk premium is the additional return an investor will receive from holding AstraZeneca PLC long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in AstraZeneca PLC. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although AstraZeneca PLC's alpha and beta are two of the key measurements used to evaluate AstraZeneca PLC's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.9761 | |||
| Semi Deviation | 1.35 | |||
| Standard Deviation | 1.43 | |||
| Variance | 2.05 |
AstraZeneca Stock Against Markets
Picking the right benchmark for AstraZeneca PLC stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in AstraZeneca PLC stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for AstraZeneca PLC is critical whether you are bullish or bearish towards AstraZeneca PLC at a given time. Please also check how AstraZeneca PLC's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in AstraZeneca PLC without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Idea Optimizer Now
Idea OptimizerUse advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |
| All Next | Launch Module |
AstraZeneca PLC Corporate Directors
AstraZeneca PLC corporate directors refer to members of an AstraZeneca PLC board of directors. The board of directors generally takes responsibility for the AstraZeneca PLC's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of AstraZeneca PLC's board members must vote for the resolution. The AstraZeneca PLC board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Marc Dunoyer | CFO and Executive Director | Profile | |
| Sherilyn McCoy | Non-Executive Director | Profile | |
| Genevieve Berger | Non-Executive Director | Profile | |
| Nazneen Rahman | Non-Executive Director | Profile |
How to buy AstraZeneca Stock?
Before investing in AstraZeneca PLC, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in AstraZeneca PLC. To buy AstraZeneca PLC stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of AstraZeneca PLC. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase AstraZeneca PLC stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located AstraZeneca PLC stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased AstraZeneca PLC stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as AstraZeneca PLC, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in AstraZeneca PLC?
The danger of trading AstraZeneca PLC is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of AstraZeneca PLC is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than AstraZeneca PLC. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile AstraZeneca PLC is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AstraZeneca PLC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Complementary Tools for AstraZeneca Stock analysis
When running AstraZeneca PLC's price analysis, check to measure AstraZeneca PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AstraZeneca PLC is operating at the current time. Most of AstraZeneca PLC's value examination focuses on studying past and present price action to predict the probability of AstraZeneca PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AstraZeneca PLC's price. Additionally, you may evaluate how the addition of AstraZeneca PLC to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |